arrow
A

Alana L. Welm

University of Utah
H指数:52
被引数:1.2万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Subclinical fields of BRAF V600E-mutant melanocytes populate human skin and are enriched around melanoma and naevi

BRAF V600E突变黑素细胞的亚临床病灶分布于人体皮肤,并在黑色素瘤和痣周围富集。

2025-12-011
PRE
The MBCRC Advocate Researcher Program (MARP): connecting advocates and researchers as collaborative partners in cancer research

MBCRC倡导者研究员计划 (MARP): 将倡导者和研究人员作为癌症研究的合作伙伴

2025-06-210
OAAI
Protective autophagy elicited by RAF→MEK→ERK inhibition suggests a treatment strategy for RAS-driven cancers (vol 25, pg 620, 2019)

RAF→MEK→ERK抑制所诱发的保护性自噬表明了一种针对RAS驱动型癌症的治疗策略(卷25,页620,2019)

2025-04-250
PRE
A Pan-Cancer Patient-Derived Xenograft Histology Image Repository with Genomic and Pathologic Annotations Enables Deep Learning Analysis
2024-07-021
OAAI
Assessment of Patient-Derived Xenograft Growth and Antitumor Activity: The NCI PDXNet Consensus Recommendations
2024-04-193
OAAI
Research autopsy programmes in oncology: shared experience from 14 centres across the world
2024-03-292
OA
Combining the Tyrosine Kinase Inhibitor Cabozantinib and the mTORC1/2 Inhibitor Sapanisertib Blocks ERK Pathway Activity and Suppresses Tumor Growth in Renal Cell Carcinoma
2023-09-273
OAAI
Endocrine Therapy Synergizes with SMAC Mimetics to Potentiate Antigen Presentation and Tumor Regression in Hormone Receptor-Positive Breast Cancer
2023-07-142
OAAI